XORTX Therapeutics XRTX Cash Flow Statement (2020-2026)

NASDAQ XRTX
$1.69 -0.01 (-0.55%)
As of: Sep 30, 2026 · 9:54 AM EDT
Reported Financials

XORTX Therapeutics Quarterly Cash Flow Statement

Periods 26 quarters
Latest Jun 2026

XORTX Therapeutics cash flow statement data for the quarter ended Jun 2026. This cash flow statement covers 26 quarters of results from Mar 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-6.64M7.21M-2.70M-1.24M-1.20M-2.15M-1.83M-1.26M-0.95M2.02M-3.02M0.17M-0.59M0.12M-0.70M-0.72M-0.65M-0.59M-0.81M-1.69M
Depreciation and DepletionDep. & Depletion
0.11M0.02M0.08M
Share-based CompensationStock Comp.
0.05M0.11M0.07M0.33M0.02M0.07M0.04M0.03M0.02M0.03M0.05M0.04M0.02M0.01M0.01M0.01M0.01M0.00M0.01M0.00M
Cash from OperationsCash from Ops.
-0.95M-3.80M
Depreciation, Depletion & Amortization
Amortizatization of IntangiblesAmort. of Intangibles
0.05M0.01M-0.00M0.01M0.01M0.01M0.01M0.01M0.01M0.00M0.00M
Depreciation & Amortization (CF)Dep. & Amort.
0.00M0.00M0.11M0.02M0.02M0.02M0.02M0.08M0.02M0.03M0.02M0.05M0.02M0.02M0.02M0.05M0.02M0.01M
Change in Working Capital
Change in ReceivablesChange Receivables
-0.08M-0.07M0.12M-0.02M0.05M0.01M-0.04M0.01M0.03M0.01M0.01M-0.00M385.000.01M-0.01M-0.06M0.02M-0.02M
Change in Accured ExpensesChange Accured Exp.
0.23M-0.01M0.13M0.04M0.71M0.09M-0.91M-0.18M0.17M-0.27M0.05M0.11M-0.11M-0.18M0.27M-0.03M99.00-0.00M0.31M-0.29M
Other Working Capital ChangesOther WC Changes
-0.02M-0.73M0.28M0.44M0.20M-0.31M0.12M0.08M0.09M-0.15M-0.40M0.43M0.11M0.07M-0.00M0.09M0.07M0.01M-0.03M-1.30M
Investing Activities
Capital ExpendituresCapex
-444.71-0.00M-0.00M-0.00M-1.00
Change in IntangiblesChange Intangibless
-0.01M-0.01M-0.00M-0.01M-0.01M-0.01M-0.02M-0.01M-0.01M-0.01M-0.00M-0.01M-0.02M-0.00M-0.00M-0.02M-0.01M-0.02M-0.00M-0.14M
Cash from Investing ActivitiesCash from Investing
-0.01M-0.02M
Financing Activities
Other financing activitiesOther financing
-0.01M-0.30M-0.02M0.09M-0.36M-0.08M-0.83M
Cash from Financing ActivitiesCash from Financing
-0.49M5.22M
Change in Capital Stock
Net Equity Issued and RepurchasedNet Equity Issued
-4.79M
Additional items
Exchange Rate EffectFX Effect
0.26M-0.13M0.27M0.48M0.05M0.00M0.00M-246.00-0.00M-0.01M-0.00M0.02M-0.04M0.00M0.03M-0.01M0.00M-763.00-0.01M
Change in Cash
-0.12M10.99M-2.64M-1.78M-0.83M1.45M-2.53M-1.74M-1.09M-1.62M0.39M-0.76M-0.78M0.17M-0.58M-0.83M0.13M-0.33M-0.61M0.74M
Beginning Cash Balance
14.88M10.43M3.45M2.47M0.86M
Free Cash FlowFCF
-0.95M-3.80M0.00M0.00M1.00
Net Cash FlowNCF
-1.44M1.40M

XORTX Therapeutics Cash Flow Statement API

Pull XORTX Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=XRTX&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY